Login / Signup

KLRF1, a novel marker of CD56 bright NK cells, predicts improved survival for patients with locally advanced bladder cancer.

Neelam MukherjeeNiannian JiXi TanChun-Liang ChenOnika D V NoelMaria Rodriguez-PadronChun-Lin LinDavid G AlonzoTim H HuangRobert S Svatek
Published in: Cancer medicine (2022)
KLRF1 is a promising prognostic marker in bladder cancer and may guide treatment decisions upon validation.
Keyphrases
  • nk cells
  • locally advanced
  • squamous cell carcinoma
  • rectal cancer
  • neoadjuvant chemotherapy
  • radiation therapy
  • combination therapy
  • phase ii study
  • lymph node
  • replacement therapy